Vivos Therapeutics, Inc. (VVOS) Insider Trading

Over the last 3 months, VVOS insiders made 3 open-market buys and 0 sales, a net purchase of $2.5M (SEC Form 4). Over the last 6 months, 6 institutions increased and 7 reduced their position (13F).

Insider Activity

Sentiment
100/100
Buys (3m)
3
Sells (3m)
0
Net (3m)
$2.5M
Insiders buying
Insider trades by month Buys Sells
Sep
Jun
Dec
Jun
Apr
Jul
Context3-month price -64.8%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Aug 26, 2026Amman Bradford K.officer: Principal Accounting OfficerGrant250,000$0.41
Aug 26, 2026Amman Bradford K.officer: Principal Accounting OfficerGrant150,000$0.41
Jul 15, 2026Skaff Michael C10 percent ownerBuy859,166$0.46
Jul 15, 2026Skaff Michael C10 percent ownerBuy2,749,330$0.46
Jul 15, 2026Skaff Michael C10 percent ownerBuy1,890,164$0.46
Apr 2, 2026Skaff Michael C10 percent ownerBuy308,848$1.34
Apr 2, 2026Skaff Michael C10 percent ownerBuy1,044,777$1.34
Apr 2, 2026Skaff Michael C10 percent ownerBuy429,957$0.00
Apr 2, 2026Skaff Michael C10 percent ownerBuy1,783,582$1.09
Nov 27, 2024Amman Bradford K.officer: Chief Financial OfficerGrant149,533$2.64
Nov 27, 2024Huntsman Ronald Kirkdirector, officer: Chief Executive OfficerGrant315,421$2.64
Jun 28, 2024Green Ralph EliasdirectorGrant4,000$2.38
Jun 28, 2024Huntsman Ronald Kirkdirector, officer: Chief Executive OfficerGrant20,000$2.38
Jun 28, 2024SOKOLOW LEONARD JdirectorGrant4,000$2.38
Jun 28, 2024Thompson MatthewdirectorGrant4,000$2.38
Jun 28, 2024Krammer Anja BdirectorGrant4,000$2.38
Jun 28, 2024Amman Bradford K.officer: Chief Financial OfficerGrant15,000$2.38
Jun 28, 2024Lindsay Mark F.directorGrant4,000$2.38
Jun 20, 2023Huntsman Ronald Kirkdirector, officer: Chief Executive OfficerBuy14,000$0.53
Jun 20, 2023Huntsman Ronald Kirkdirector, officer: Chief Executive OfficerBuy5,000$0.53
Jun 20, 2023Huntsman Ronald Kirkdirector, officer: Chief Executive OfficerBuy10,000$0.54
Jun 20, 2023Huntsman Ronald Kirkdirector, officer: Chief Executive OfficerBuy21$0.50
Jun 15, 2023Huntsman Ronald Kirkdirector, officer: Chief Executive OfficerBuy10,000$0.49
Dec 28, 2022Huntsman Ronald Kirkofficer: Chief Executive OfficerGrant333,334$0.48
Dec 28, 2022Huntsman Ronald Kirkofficer: Chief Executive OfficerBuy20,000$0.50
Dec 28, 2022Lindsay Mark F.directorGrant30,000$0.48
Dec 28, 2022Amman Bradford K.officer: Chief Financial OfficerGrant200,000$0.48
Dec 28, 2022Green Ralph EliasdirectorGrant30,000$0.48
Dec 28, 2022Huntsman Ronald Kirkofficer: Chief Executive OfficerGrant150,000$0.48
Dec 28, 2022Thompson MatthewdirectorGrant30,000$0.48

Source: VVOS SEC Form 4 filings, latest Aug 26, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their VVOS positions over the last 6 months (SEC Form 13F).

Increased
6
New positions
11
Reduced
7
Sold out
4
Largest moves
InstitutionActionSharesFiled
ARMISTICE CAPITAL, LLCNew Position1.1MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position273KMay 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased96KMay 15, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced85KAug 12, 2026
IHT Wealth Management, LLCIncreased77KAug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCReduced61KAug 13, 2026
COMMONWEALTH EQUITY SERVICES, LLCUnchanged43KJul 29, 2026
COMMONWEALTH EQUITY SERVICES, LLCIncreased43KApr 27, 2026
IHT WEALTH MANAGEMENT, LLCNew Position41KMay 15, 2026
UBS Group AGIncreased39KAug 13, 2026
B. Riley Wealth Advisors, Inc.Unchanged38KJul 14, 2026
B. RILEY WEALTH ADVISORS, INC.Reduced38KApr 27, 2026
Centurion Wealth Management LLCUnchanged36KJul 9, 2026
CENTURION WEALTH MANAGEMENT LLCNew Position36KApr 13, 2026
VANGUARD FIDUCIARY TRUST CONew Position31KMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.